# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
B of A Securities analyst Omar Dessouky reinstates Cardlytics (NASDAQ:CDLX) with a Neutral and announces $11 price target.
Northland Capital Markets analyst Luke Horton initiates coverage on Cardlytics (NASDAQ:CDLX) with a Outperform rating and an...
Needham analyst Kyle Peterson reiterates Cardlytics (NASDAQ:CDLX) with a Buy and maintains $12 price target.
Craig-Hallum analyst Jason Kreyer maintains Cardlytics (NASDAQ:CDLX) with a Buy and lowers the price target from $18 to $12.